These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 8545592)

  • 1. Nodular lymphocyte predominant Hodgkin's disease and anaplastic large-cell (CD30+) lymphoma: distinct entities or nonspecific patterns?
    Menestrina F; Chilosi M; Scarpa A
    Semin Diagn Pathol; 1995 Aug; 12(3):256-69. PubMed ID: 8545592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.
    Pinkus GS; Said JW
    Am J Pathol; 1988 Nov; 133(2):211-7. PubMed ID: 3263805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
    Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
    Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hodgkin's disease and anaplastic large cell lymphoma in 1998].
    Delsol G; Lamant L; al Saati T; Auvigne I; Brousset P
    Ann Pathol; 1998 Oct; 18(4):331-42. PubMed ID: 9827224
    [No Abstract]   [Full Text] [Related]  

  • 5. [Dipeptidyl aminopeptidase-IV as a histochemical marker of differential diagnosis of large cell anaplastic CD30+-lymphoma and Hodgkin's disease].
    Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Pavlovskaia AI; Tupitsyn NN; Sholokhova EN
    Arkh Patol; 2000; 62(4):3-8. PubMed ID: 10971865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology.
    Jaffe ES
    Mod Pathol; 2001 Mar; 14(3):219-28. PubMed ID: 11266530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T-bet, a T cell-associated transcription factor, is expressed in Hodgkin's lymphoma.
    Dorfman DM; Hwang ES; Shahsafaei A; Glimcher LH
    Hum Pathol; 2005 Jan; 36(1):10-5. PubMed ID: 15712176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD30 expression utilization for the accuracy of classical Hodgkin's lymphoma staging.
    Flangea C; Potencz E; Mihăescu R; Anghel A; Gîju S; Motoc M; Dogaru C
    Rom J Morphol Embryol; 2006; 47(2):113-7. PubMed ID: 17106517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pathology of Hodgkin's lymphoma].
    Hansmann ML; Willenbrock K
    Verh Dtsch Ges Pathol; 2003; 87():53-7. PubMed ID: 16888894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histopathology of Hodgkin's lymphoma.
    Eberle FC; Mani H; Jaffe ES
    Cancer J; 2009; 15(2):129-37. PubMed ID: 19390308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD30 in normal and neoplastic cells.
    Chiarle R; Podda A; Prolla G; Gong J; Thorbecke GJ; Inghirami G
    Clin Immunol; 1999 Feb; 90(2):157-64. PubMed ID: 10080826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Light-chain mRNA in lymphocyte-predominant and mixed-cellularity Hodgkin's disease.
    von Wasielewski R; Wilkens L; Nolte M; Werner M; Georgii A
    Mod Pathol; 1996 Mar; 9(3):334-8. PubMed ID: 8685237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphologically normal, CD30-negative B-lymphocytes with chromosome aberrations in classical Hodgkin's disease: the progenitor cell of the malignant clone?
    Jansen MP; Hopman AH; Bot FJ; Haesevoets A; Stevens-Kroef MJ; Arends JW; Jox A; Wolf J; Ramaekers FC; Schouten HC
    J Pathol; 1999 Dec; 189(4):527-32. PubMed ID: 10629553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fascin, a sensitive new marker for Reed-Sternberg cells of hodgkin's disease. Evidence for a dendritic or B cell derivation?
    Pinkus GS; Pinkus JL; Langhoff E; Matsumura F; Yamashiro S; Mosialos G; Said JW
    Am J Pathol; 1997 Feb; 150(2):543-62. PubMed ID: 9033270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interface of Hodgkin's disease and anaplastic large cell lymphoma.
    Chittal SM; Delsol G
    Cancer Surv; 1997; 30():87-105. PubMed ID: 9547988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic molecule expression is predictive of prognosis in Hodgkin's-like anaplastic large cell lymphoma.
    Asano N; Suzuki R; Matsuo K; Kagami Y; Ishida F; Tamaru JI; Jin GS; Sato Y; Shimoyama Y; Yoshino T; Morishima Y; Nakamura S
    Histopathology; 2007 May; 50(6):705-15. PubMed ID: 17493234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anaplastic lymphoma versus Hodgkin's disease. Diagnosis, Controversies].
    Rivas C; Ageitos AG; Oliva H
    Sangre (Barc); 1995 Aug; 40(4):265-8. PubMed ID: 7482113
    [No Abstract]   [Full Text] [Related]  

  • 18. Inflammatory malignant fibrous histiocytoma: distinction from Hodgkin's disease and non-Hodgkin's lymphoma by a panel of leukocyte markers.
    Khalidi HS; Singleton TP; Weiss SW
    Mod Pathol; 1997 May; 10(5):438-42. PubMed ID: 9160307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hodgkin's disease: classification and differential diagnosis.
    Harris NL
    Mod Pathol; 1999 Feb; 12(2):159-75. PubMed ID: 10071341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus-negative Hodgkin's lymphoma after mycosis fungoides: molecular evidence for distinct clonal origin.
    Kremer M; Sandherr M; Geist B; Cabras AD; Höfler H; Fend F
    Mod Pathol; 2001 Feb; 14(2):91-7. PubMed ID: 11235910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.